Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.23 USD | +4.24% | +7.89% | -30.90% |
May. 10 | Transcript : Protalix BioTherapeutics, Inc., Q1 2024 Earnings Call, May 10, 2024 | |
May. 10 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Bearish | Bearish |
Resistance | 1.290 | 1.420 | 1.620 |
Spread/Res. | -4.65% | -13.38% | -24.07% |
Spread/Supp. | +11.82% | +11.82% | +11.82% |
Support | 1.100 | 1.100 | 1.100 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- PLX Stock
- Charts Protalix BioTherapeutics, Inc.